COMPANIES COVERED
ActelionDownload FREE Report Sample
Download Free samplePulmonary Arterial Hypertension Market contains market size and forecasts of Pulmonary Arterial Hypertension (PAH) in Global, including the following market information:
Global Pulmonary Arterial Hypertension (PAH) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pulmonary Arterial Hypertension (PAH) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prostacyclin and Prostacyclin Analogs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Arterial Hypertension (PAH) include Actelion, Gilead Sciences, United Therapeutics, GlaxoSmithKline, Pfizer, Bayer and Arena, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pulmonary Arterial Hypertension (PAH) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Arterial Hypertension (PAH) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pulmonary Arterial Hypertension (PAH) Market Segment Percentages, by Type, 2021 (%)
Prostacyclin and Prostacyclin Analogs
SGC Stimulators
ERA
PDE-5
Global Pulmonary Arterial Hypertension (PAH) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pulmonary Arterial Hypertension (PAH) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Pulmonary Arterial Hypertension (PAH) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pulmonary Arterial Hypertension (PAH) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Arterial Hypertension (PAH) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pulmonary Arterial Hypertension (PAH) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Actelion
Gilead Sciences
United Therapeutics
GlaxoSmithKline
Pfizer
Bayer
Arena
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
